| Dr George N Chin, MD | |
|
10564 5th Ave Ne, Suite 102, Seattle, WA 98125-7200 | |
| (206) 365-5800 | |
| (206) 364-2072 |
| Full Name | Dr George N Chin |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 10564 5th Ave Ne, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114020146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD00015647 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr George N Chin, MD 10564 5th Ave Ne, Suite 102, Seattle, WA 98125-7200 Ph: (206) 365-5800 | Dr George N Chin, MD 10564 5th Ave Ne, Suite 102, Seattle, WA 98125-7200 Ph: (206) 365-5800 |
News Archive
Elekta today announced the acquisition of Resonant Medical Inc., Montreal Canada. Through this acquisition, Elekta adds exciting new solutions for image guidance as well as highly skilled R&D resources in the field of oncology imaging and motion management.
Improving diagnosis and treatment for individuals with autism has been the focus of a growing body of research. New information from these studies led the American Academy of Child and Adolescent Psychiatry to revise key parameters for evaluating and treating autism. Researchers led by Yale Child Study Center director Fred Volkmar, M.D., have published the new practice parameters in the Feb. issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
In rare cases, people who have been fully vaccinated against COVID and are immune to the virus can nevertheless develop the disease.
Skin cells from a patient with an inherited heart disease were the seeds of a stem cell experiment that could help researchers test specific treatments for the disease, known as long QT syndrome. The research results appear in the January 16 issue of the journal Nature.
The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) today announced the latest grant recipients of its New Therapy Grants Program, a unique joint venture of the non-profit epilepsy organizations, to advance promising epilepsy research in clinical development. The grant awards, totaling approximately $200,000 in funding, will support an experimental gene therapy that directly targets epileptogenic brain tissue, as well as an electrode system that has the potential to improve the efficacy of surgical therapies for certain epilepsy syndromes.
› Verified 8 days ago
Rika Shirakawa, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1959 Ne Pacific St, Box 365485, Seattle, WA 98195 Phone: 206-558-9616 | |
Dr. Ted M Zollman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1101 Madison St, Ste. 600, Seattle, WA 98104 Phone: 206-215-2020 Fax: 206-215-2022 | |
Timothy Patrick Carey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5116 25th Ave Ne, Seattle, WA 98105 Phone: 206-522-2500 Fax: 206-269-8307 | |
Kristina Tarczy-hornoch, M.D Ophthalmology Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, M/s W-7729, Seattle, WA 98105 Phone: 206-987-3670 | |
Miss Miel Sundararajan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Arthika Chandramohan, Ophthalmology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 | |
Eun Sara Huh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10330 Meridian Ave N, Suite 370, Seattle, WA 98133 Phone: 206-528-6000 Fax: 206-528-0014 |